These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20681062)

  • 41. Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
    Burty C; Prazuck T; Truchetet F; Christian B; Penalba C; Salmon-Ceron D; Yazdanpanah Y; May T; Rabaud C
    AIDS Patient Care STDS; 2010 Jan; 24(1):1-3. PubMed ID: 20095911
    [No Abstract]   [Full Text] [Related]  

  • 42. HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial.
    Garrett NJ; Werner L; Naicker N; Naranbhai V; Sibeko S; Samsunder N; Gray C; Williamson C; Morris L; Abdool-Karim Q; Abdool-Karim SS
    J Acquir Immune Defic Syndr; 2015 Jan; 68(1):55-61. PubMed ID: 25247433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Report from the XVI International AIDS Conference. Preexposure prophylaxis studies move forward.
    Sax PE
    AIDS Clin Care; 2006 Nov; 18(11):101-2. PubMed ID: 17186582
    [No Abstract]   [Full Text] [Related]  

  • 44. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
    J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?
    Estebanez M; Stella-Ascariz N; Ruiz-Carrascoso G; Zamora FX; García-Bujalance S; Bernardino JI; Pérez-Valero I; Martin-Quirós A; Mingorance J; Arribas JR
    AIDS; 2013 Jan; 27(1):141-4. PubMed ID: 22914581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW
    J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The preventive misconception: experiences from CAPRISA 004.
    Dellar RC; Abdool Karim Q; Mansoor LE; Grobler A; Humphries H; Werner L; Ntombela F; Luthuli L; Abdool Karim SS
    AIDS Behav; 2014 Sep; 18(9):1746-52. PubMed ID: 24715227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
    Myer L; Kamkuemah M; Kaplan R; Bekker LG
    Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 50. Reformulated tenofovir gel for use as a dual compartment microbicide.
    Dezzutti CS; Rohan LC; Wang L; Uranker K; Shetler C; Cost M; Lynam JD; Friend D
    J Antimicrob Chemother; 2012 Sep; 67(9):2139-42. PubMed ID: 22581908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. South Africans win MTCT court case.
    Achmat Z
    WORLD; 2002 Jan; (129):6. PubMed ID: 12141243
    [No Abstract]   [Full Text] [Related]  

  • 52. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbicide research already benefiting thousands--experts.
    Bateman C
    S Afr Med J; 2009 Sep; 99(9):628-30. PubMed ID: 20073283
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral tenofovir arm of VOICE trial discontinued early.
    McEnery R
    IAVI Rep; 2011; 15(5):21. PubMed ID: 22121550
    [No Abstract]   [Full Text] [Related]  

  • 55. Loss of control of HIV viremia associated with the fat malabsorption drug orlistat.
    Kent SJ
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):961-2. PubMed ID: 22280308
    [No Abstract]   [Full Text] [Related]  

  • 56. In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers.
    Viganò A; Mora S; Giacomet V; Stucchi S; Manfredini V; Gabiano C; Salvini F; Cellini M; Tamburrini E; Puzzovio M; Zuccotti GV
    Antivir Ther; 2011; 16(8):1259-66. PubMed ID: 22155907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling interventions to assess HIV epidemic impact in Africa.
    Vermund SH
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):121-4. PubMed ID: 21857360
    [No Abstract]   [Full Text] [Related]  

  • 58. The North Carolina contribution to the CAPRISA 004 study: the Global Health Initiative in action.
    Cates W; Kashuba AD
    N C Med J; 2010; 71(5):490-1. PubMed ID: 21473558
    [No Abstract]   [Full Text] [Related]  

  • 59. Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial.
    Naranbhai V; Altfeld M; Abdool Karim Q; Ndung'u T; Abdool Karim SS; Carr WH;
    AIDS; 2012 Sep; 26(14):1745-53. PubMed ID: 22781225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of specific antiretroviral regimens among HIV-infected women in Italy at time of conception: 2001-2011.
    Floridia M; Ravizza M; Guaraldi G; Pinnetti C; Martinelli P; Tamburrini E;
    AIDS Patient Care STDS; 2012 Aug; 26(8):439-43. PubMed ID: 22663250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.